Claims for Patent: 10,036,054

Summary for Patent: 10,036,054

Title:	Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms
Abstract:	The present disclosure provides improved methods for bead beating and a bead beating system useful therefor. The bead beating system comprises a sample tube, beads, and a dry blocking agent, and methods for using the bead beating system to extract nucleic acids from cells containing the nucleic acids.
Inventor(s):	Klapproth; Holger (Freiburg, DE), Smit; Nicolaas (Welland, CA)
Assignee:	Safeguard Biosystems Holdings Ltd. (London, GB)
Application Number:	15/432,157
Patent Claims:	1. A method for producing a lysate from cells contained in a liquid sample comprising blood or a sample processed, extracted or fractionated from blood, the method comprising: (a) agitating the liquid sample within a bead beating system in the absence of lysis buffer and in the presence of one or more blocking agents under conditions sufficient to lyse the cells, said bead beating system comprising a bead beating tube and beads; and (b) separating the liquid sample from the beads directly following the agitating, thereby producing a lysate. 2. A method for producing a lysate from cells contained in a liquid sample comprising blood, the method comprising: (a) agitating the liquid sample within a bead beating system in the absence of lysis buffer and in the presence of one or more blocking agents under conditions sufficient to lyse the cells, said bead beating system comprising a bead beating tube and beads; and (b) separating the liquid sample from the beads following the agitating, thereby producing a lysate. 3. The method of claim 2, wherein the liquid sample contains an endogenous blocking agent. 4. The method of claim 3, wherein the agitating is carried out in the absence of additives. 5. The method of claim 3, wherein the agitating is carried out in the absence of additives which comprise a buffer. 6. The method of any one of claims 2 to 5, wherein the agitating is carried out in the absence of additives which comprise a detergent. 7. The method of claim 1 or claim 2, wherein the one or more blocking agents are exogenous to the liquid sample. 8. The method of claim 1 or claim 2, further comprising a step of placing the liquid sample within the bead beating tube prior to agitating the liquid sample. 9. The method of claim 1 or claim 2, wherein the agitating comprises subjecting the bead beating system to an oscillating motion. 10. The method of claim 1 or claim 2, wherein the cells comprise one or more pathogens. 11. The method of claim 10, wherein the one or more pathogens comprise one or more bacterial pathogens, viral pathogens, fungal pathogens, or a combination thereof. 12. The method of claim 10, wherein the one or more pathogens comprise one or more of Mycobacterium tuberculosis, Mycobacterium avium subsp paratuberculosis, Staphylococcus aureus, methicillin resistant Staphylococcus aureus (MRSA), Streptococcus pyogenes, Streptococcus pneumoniae, Streptococcus agalactiae, Haemophilus influenzae, Haemophilus parainfuluezae, Moraxella catarrhalis, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter sp., Bordetella pertussis, Neisseria meningitidis, Bacillus anthracis, Nocardia sp., Actinomyces sp., Mycoplasma pneumoniae, Chlamydia pneumonia, Legionella species, Pneumocystis jiroveci, influenza A virus, cytomegalovirus, rhinovirus, Enterococcus faecium, Acinetobacter baumannii, Corynebacterium amycolatum, Enterobacter aerogenes, Enterococcus faecalis CI 4413, Serratia marcescens, Streptococcus equi, and Candida albicans. 13. The method of claim 1, wherein the liquid sample comprises blood. 14. The method of claim 1, wherein the liquid sample comprises a sample processed, extracted or fractionated from blood. 15. The method of claim 1 or claim 2, wherein step (b) comprises pipetting the liquid sample from the bead beating tube, thereby leaving behind the beads in the bead beating tube. 16. The method of claim 1 or claim 2, further comprising purifying the nucleic acids from the lysate. 17. The method of claim 16, further comprising analyzing one or more of the nucleic acids.

Details for Patent 10,036,054

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emergent Biodefense Operations Lansing Llc	BIOTHRAX	anthrax vaccine adsorbed	Injection	103821	11/12/1998		2036-01-30